Today’s Research Report Coverage on Health Care Plans Stocks — Express Scripts, Health Insurance

If you want a Stock Review on ESRX, HIIQ, AET, or CI then come over to and sign up for your free customized report today. Four Health Care Plans companies have been lined up by for review today: Express Scripts Holding Co. (NASDAQ: ESRX), Health Insurance Innovations Inc. (NASDAQ: HIIQ), Aetna Inc. (NYSE: AET), and Cigna Corp. (NYSE: CI). These equities operate in the Healthcare sector, which has received an “Outperform” rating from Charles Schwab on August 17th, 2017, due to solid balance sheets, attractive dividend yields, and an improved overall cost structure. Learn more about these stocks by signing up for their free reports on at:


Express Scripts 

On Monday, shares in Missouri headquartered Express Scripts Holding Co. recorded a trading volume of 2.65 million shares. The stock ended the session 0.38% lower at $60.33. The Company’s shares have gained 0.03% over the previous three months. The stock is trading 3.77% below its 50-day moving average. Moreover, shares of the Company, which operates as a pharmacy benefit management company, have a Relative Strength Index (RSI) of 36.01.

On July 25th, 2017, Express Scripts announced Q2 2017 results. For Q2 2017, revenues were $25.3 billion; GAAP net income was $801.8 million; and EBITDA was $1.8 billion. For its 2017 guidance, the Company increased adjusted earnings per diluted share from a range of $6.90 to $7.04 to a range of $6.95 to $7.05, which represents growth of 10% over 2016 adjusted earnings per diluted share results at the mid-point of the range. The free research report on ESRX is available at:


Health Insurance Innovations 

Florida-based Health Insurance Innovations Inc.’s stock closed the day 0.30% lower at $33.00 with a total trading volume of 255,257 shares. The Company’s shares have surged 17.65% in the past month, 64.18% in the previous three months, and 84.87% since the start of this year. The stock is trading 23.31% and 72.86% above its 50-day and 200-day moving averages, respectively. Additionally, shares of the Company, which operates as a developer, distributor, and administrator of cloud-based individual health and family insurance plans, and supplemental products, have an RSI of 66.56.

On August 02nd, 2017, Health Insurance Innovations announced financial results for Q2 ended June 30th, 2017. For Q2 2017, revenue was a record $61.8 million; total collections from customers (premium equivalents) were a record $98.9 million; and adjusted EBITDA was a record $12.5 million. Policies in force as of June 30th, 2017 totaled a record of approximately 359,500 – a 39.1% increase from 258,400 as of June 30th, 2016. The complimentary report on HIIQ can be downloaded at:



Shares in Connecticut-based Aetna Inc. recorded a trading volume of 1.25 million shares. The stock ended yesterday’s trading session 0.19% higher at $154.74. The Company’s shares have advanced 9.74% in the previous three months and 24.78% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 0.72% and 14.41%, respectively. Furthermore, shares of Aetna, which operates as a health care benefits company, have an RSI of 49.23.

On August 04th, 2017, research firm RBC Capital Markets reiterated its ‘Outperform’ rating on the Company’s stock with an increase of the target price from $162 a share to $171 a share.

On August 10th, 2017, Aetna announced that it has completed a public offering of $1 billion of 3.875% senior notes due in 2047. The Company intends to use the proceeds of the offering to repay a portion of its 1.5% senior notes and floating-rate senior notes, both due in 2017, and for general corporate purposes. Visit us today and download our complete research report on AET for free at:



Connecticut headquartered Cigna Corp.’s stock finished Monday’s session 0.54% higher at $177.98 with a total trading volume of 1.07 million shares. The Company’s shares have advanced 2.15% in the last one month, 11.69% over the previous three months, and 33.43% since the start of this year. The stock is trading above its 50-day and 200-day moving averages by 3.44% and 15.97%, respectively. Additionally, shares of Cigna, which provides insurance and related products and services, have an RSI of 56.98.

On August 09th, 2017, Cigna has signed on as a corporate sponsor of the Hartford Yard Goats minor league baseball team for the 2017 and 2018 seasons. As part of the sponsorship, the Company will set up its Health Improvement Tour at select games. The Health Improvement tour is a mobile health clinic that brings free health screenings and health coaching to communities across the US. Get free access to your technical report on CI at:


Daily Stock Tracker: 

Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

DST has not been compensated; directly or indirectly; for producing or publishing this document. 


The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  


DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

For any questions, inquiries, or comments reach out to us directly. If youre a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: (207)331-3313
Office Address: 377 Rivonia Boulevard, Rivonia, South Africa

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Chelmsford Park SA


Please enter your comment!
Please enter your name here

twelve − 8 =